Cargando…
The role of Asprosin in patients with dilated cardiomyopathy
BACKGROUND: Asprosin is a novel fasting glucogenic adipokine discovered in 2016. Asprosin induces rapid glucose releases from the liver. However, its molecular mechanisms and function are still unclear. Adaptation of energy substrates from fatty acid to glucose is recently considered a novel therape...
Autores principales: | Wen, Ming-Shien, Wang, Chao-Yung, Yeh, Jih-Kai, Chen, Chun-Chi, Tsai, Ming-Lung, Ho, Ming-Yun, Hung, Kuo-Chun, Hsieh, I-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487662/ https://www.ncbi.nlm.nih.gov/pubmed/32894050 http://dx.doi.org/10.1186/s12872-020-01680-1 |
Ejemplares similares
-
TLR9 Binding to Beclin 1 and Mitochondrial SIRT3 by a Sodium-Glucose Co-Transporter 2 Inhibitor Protects the Heart from Doxorubicin Toxicity
por: Wang, Chao-Yung, et al.
Publicado: (2020) -
Angiographic Complete versus Clinical Selective Incomplete Percutaneous Revascularization in Heart Failure Patients with Multivessel Coronary Disease
por: Chang, Chieh-Yu, et al.
Publicado: (2020) -
Comparison of clinical outcomes in peripartum cardiomyopathy and age-matched dilated cardiomyopathy: A 15-year nationwide population-based study in Asia
por: Lu, Cheng-Hui, et al.
Publicado: (2017) -
FTO modulates fibrogenic responses in obstructive nephropathy
por: Wang, Chao-Yung, et al.
Publicado: (2016) -
Impact of Homocysteine Level on Long-term Cardiovascular Outcomes in Patients after Coronary Artery Stenting
por: Yeh, Jih-Kai, et al.
Publicado: (2017)